Business of Medicine

What to Look for When Choosing a Group Health Insurance Provider

By Guest Author A group health insurance plan covers a specified group of people. Group health plans are often offered as employee benefits by employers who might choose to pay a portion (or all, or none) of the premium. Group health insurance is a great benefit for people with preexisting conditions or health issues, who [...]

Read the full article →

Pharma Patient Connection: Insight is the Missing Link to Authenticity

This is based on a presentation I gave to DTC Perspectives’ Marketing to the Digital Consumer conference, October 12-13, 2011 in Fairfield New Jersey. Authenticity in Pharma-Patient Connection

Read the full article →

Toward a National Drug Control Strategy

By Guest Author (Brandon) Prescription drugs have become part of the American society and have been a controversial topic among government officials.  The United States Government is trying control and prevent the amount of drug use that occurs among the American population.  Prescription drugs have been abused over the recent years and that has caused [...]

Read the full article →

Pharma Companies that Can’t Handle Comments Should Get Off Facebook, Good Riddance!

Jonathan at Dose of Digital talks about pharma’s fear of Facebook pages centering around 2 issues that pharma thinks require 24/7 monitoring: Adverse Events and negative publicity. I hear the same excuse on why pharma companies are so scared to look at patient comments on blogs: adverse events. I’m sorry, but adverse events are happening [...]

Read the full article →

Stop Pretending You Don’t Know, Pharma Companies!

I remembered years ago I was speaking to a Forest employee who told me how proud she was to be working at Forest because of how ethical the company and the CEO was. That same employee was critical of me for talking to the WSJ about some of the less ethical practices that pharma companies [...]

Read the full article →

← Previous Entries